Hirsch EC - Search Results

1

Does the calcium binding protein calretinin protect dopaminergic neurons against degeneration in Parkinson's disease?

Mouatt-Prigent A, Agid Y, Hirsch EC. Mouatt-Prigent A, et al. Among authors: hirsch ec. Brain Res. 1994 Dec 30;668(1-2):62-70. doi: 10.1016/0006-8993(94)90511-8. Brain Res. 1994. PMID: 7704619

2

Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content?

Kastner A, Hirsch EC, Lejeune O, Javoy-Agid F, Rascol O, Agid Y. Kastner A, et al. Among authors: hirsch ec. J Neurochem. 1992 Sep;59(3):1080-9. doi: 10.1111/j.1471-4159.1992.tb08350.x. J Neurochem. 1992. PMID: 1494900

3

Catecholaminergic systems in the medulla oblongata in parkinsonian syndromes: a quantitative immunohistochemical study in Parkinson's disease, progressive supranuclear palsy, and striatonigral degeneration.

Malessa S, Hirsch EC, Cervera P, Duyckaerts C, Agid Y. Malessa S, et al. Among authors: hirsch ec. Neurology. 1990 Nov;40(11):1739-43. doi: 10.1212/wnl.40.11.1739. Neurology. 1990. PMID: 1978260

4

Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson's disease: an in situ hybridization study.

Javoy-Agid F, Hirsch EC, Dumas S, Duyckaerts C, Mallet J, Agid Y. Javoy-Agid F, et al. Among authors: hirsch ec. Neuroscience. 1990;38(1):245-53. doi: 10.1016/0306-4522(90)90389-l. Neuroscience. 1990. PMID: 1979431

5

Microtopography of D1 dopaminergic binding sites in the human substantia nigra: an autoradiographic study.

Thibaut F, Hirsch EC, Raisman R, Javoy-Agid F, Agid Y. Thibaut F, et al. Among authors: hirsch ec. Neuroscience. 1990;37(2):387-98. doi: 10.1016/0306-4522(90)90409-w. Neuroscience. 1990. PMID: 1983469

6

Does adrenal graft enhance recovery of dopaminergic neurons in Parkinson's disease?

Hirsch EC, Duyckaerts C, Javoy-Agid F, Hauw JJ, Agid Y. Hirsch EC, et al. Ann Neurol. 1990 Jun;27(6):676-82. doi: 10.1002/ana.410270615. Ann Neurol. 1990. PMID: 2360804

7

Selective vulnerability of pigmented dopaminergic neurons in Parkinson's disease.

Hirsch EC, Graybiel AM, Agid Y. Hirsch EC, et al. Acta Neurol Scand Suppl. 1989;126:19-22. doi: 10.1111/j.1600-0404.1989.tb01778.x. Acta Neurol Scand Suppl. 1989. PMID: 2575832

8

Monoamine vesicular uptake sites in patients with Parkinson's disease and Alzheimer's disease, as measured by tritiated dihydrotetrabenazine autoradiography.

Lehéricy S, Brandel JP, Hirsch EC, Anglade P, Villares J, Scherman D, Duyckaerts C, Javoy-Agid F, Agid Y. Lehéricy S, et al. Among authors: hirsch ec. Brain Res. 1994 Oct 3;659(1-2):1-9. doi: 10.1016/0006-8993(94)90856-7. Brain Res. 1994. PMID: 7820649

9

Plasticity of nerve afferents to nigrostriatal neurons in Parkinson's disease.

Anglade P, Tsuji S, Javoy-Agid F, Agid Y, Hirsch EC. Anglade P, et al. Among authors: hirsch ec. Ann Neurol. 1995 Feb;37(2):265-72. doi: 10.1002/ana.410370219. Ann Neurol. 1995. PMID: 7847868

10

High affinity neurotrophin receptors in cholinergic neurons in the human brain.

Boissière F, Hunot S, Faucheux B, Mouatt-Prigent A, Agid Y, Hirsch EC. Boissière F, et al. Among authors: hirsch ec. C R Acad Sci III. 1994 Nov;317(11):997-1003. C R Acad Sci III. 1994. PMID: 7882144

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

326 results

Search Page

Filters